Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|HER-2 Gene Amplification
Sponsor: University Hospital, Brest